By attorneys with Lowenstein Sandler LLP (January 27, 2017, 12:42 PM EST) -- James C. Shehan
Tara P. D'Orsi
Donna E. Hanrahan
By releasing two draft guidances on medical product communications on Jan. 18, the U.S. Food and Drug Administration has broken its long silence on medical product communications. The timing of the release in the waning days of the Obama administration appears to be an effort by the FDA to get its position on the record in an attempt to avoid being trumped by the incoming administration; that effort may be thwarted by the current administration's move to roll back recently issued regulations.
One draft guidance addresses drug and device manufacturer communications with...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!